Assessment and management of glucocorticoid‐induced osteoporosis

Abstract

Glucocorticoid‐induced osteoporosis (GIO) is the most prevalent form of secondary osteoporosis; however, many patients taking glucocorticoids are still missing out on fracture risk assessments and boneprotection therapy. This article describes the clinical features, assessment and recommended management of GIO.